Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
Opinion
The Well News on MSNOpinion
Rewriting the aging code: How AI is accelerating clinical rejuvenation
For decades, the idea of resetting the biological clock sounded more like speculative fiction than clinical strategy. The discovery of Yamanaka factors by Nobel laureate Shinya Yamanaka, which can ...
Explore the implications of the IVNS1ABP gene in a new genetic disease linked to premature aging and neurological decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results